Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BIO · against 160 other Healthcare companies of similar size
Ranked #116 of 161 · scores higher than 28% of peers
Bars: peers in each 10-point band of the profitability score12 peers with a profitability score of 50–59, including BIO · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | BIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 157 reported | 4.1% | 10.0% | 31% | 33% | |
| Operating marginHigher is better · 153 reported | 8.5% | 13.5% | 31% | 33% | |
| Return on assetsHigher is better · 155 reported | 1.7% | 4.7% | 33% | 33% | |
| Return on equityHigher is better · 150 reported | 3.1% | 9.2% | 30% | Context only | |
| Gross marginHigher is better · 170 reported | 52.0% | 55.0% | 47% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 548.2B INR (≈$6.6B) | 98 | 68 | |
| 5 | 18.5B USD | 97 | 62 | |
| 111 | 4.4B CHF (≈$5.1B) | 54 | 47 | |
| 113 | 66.0B BRL (≈$11.9B) | 53 | 55 | |
| 113 | 5.9B USD | 53 | 39 | |
| 115 | 12.7B AUD (≈$8.4B) | 52 | 38 | |
| 116 | 10.0B USD | 50 | 43 | |
| 117 | 45.1B HKD (≈$5.8B) | 49 | 53 | |
| 118 | 1.03T JPY (≈$7.0B) | 48 | 64 | |
| 118 | 8.9B USD | 48 | 51 | |
| 120 | 7.7B USD | 47 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score